| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52a24331fe7882d8a0801155df05d542 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_618953ba79cc6dc7cabd430b1c991451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c73cf8e32c37cfabb958cc918c1650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd1da5eb24342bf5d75fe874dd1f7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8498389abe83ba83033b8f72ff61ca72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a37d827bf5c20a3f727f4001e0634e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9832ac9e07e50dbe8053e19efbee70cd |
| publicationDate |
2010-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010209491-A1 |
| titleOfInvention |
Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv |
| abstract |
A method for enhancing the serum stability and lowering the immunostimulatory property of a small interfering ribonucleic acid (siRNA) which mediates RNA interference (RNAi) against a viral gene expression of hepatitis B virus (HBV) or hepatitis C virus (HCV) is provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11685921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534453-B2 |
| priorityDate |
2007-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |